Robert J. Hamilton
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Papers
9
Total Citations
119
H-Index
7
About
Dr. Robert J. Hamilton is a leading urologic oncologist whose research centers on advancing surgical techniques for testicular cancer, with a particular focus on robotic and minimally invasive approaches. His major contributions include pioneering the safety and feasibility of robotic retroperitoneal lymph node dissection (RPLND) for both primary and post-chemotherapy testis cancer, as demonstrated in his 2022 study (27 citations) and a 2024 propensity-matched analysis (21 citations) showing comparable outcomes to open surgery. Hamilton’s work has been instrumental in establishing robotic RPLND as a viable option, reducing morbidity while maintaining oncologic efficacy. His impact is reflected in over 100 citations across his top papers, including a 2024 multicenter study (10 citations) validating oncological outcomes worldwide. Beyond testicular cancer, he has explored health-related quality of life in robotic versus open prostatectomy (2015, 9 citations). Notably, his research from the Princess Margaret Cancer Centre has shaped global practice, and he has actively engaged in scholarly discourse, as seen in his response to a 2019 European Urology article. Hamilton’s contributions continue to drive innovation in urologic oncology, offering patients less invasive options without compromising cancer control.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4The Role of Robotic Retroperitoneal Lymph Node Dissection for Testis Cancer13 citations · 2019
- 5Robotic RPLND for stage IIA/B nonseminoma: the Princess Margaret Experience13 citations · 2022
- 6
- 7
- 8
- 9